Bioresorbable vascular scaffold versus everolimus-eluting stents or drug eluting balloon for the treatment of coronary in-stent restenosis: 1-Year follow-up of a propensity score matching comparison (the BIORESOLVE-ISR Study)
- Moscarella, Elisabetta
- Tanaka, Akihito
- Ielasi, Alfonso
- Cortese, Bernardo
- Coscarelli, Sebastian
- De Angelis, Maria Carmen
- Piraino, Davide
- Latib, Azeem
- Grigis, Giulietta
- Bianchi, Renatomaria
- Buccheri, Dario
- Calabrò, Paolo
- Tespili, Maurizio
- Silva Orrego, Pedro
- Colombo, Antonio
- Varricchio, Attilio
DOIAbstract
to compare the 1-year outcome between bioresorbable vascular scaffold (BVS), everolimus-eluting stent (EES), and drug-eluting balloon (DEB) for in-stent restenosis (ISR) treatment
Add to ORKG